Company intelligence / Profile preview
Ark Biosciences
Shanghai*, Shanghai, Chinaarkbiosciences.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Ark Biosciences is a clinical-stage biopharmaceutical company developing therapeutics for respiratory, infectious, and pediatric diseases. Its lead RSV program AK0529 has completed global Phase 3 trials with an NDA accepted and granted Priority Review by China's NMPA. The anti-fibrotic molecule AK3280 is in Phase II for IPF with promising safety/tolerability data. Other pipeline assets include drugs for COPD, hypertrophic scars, and ADHD—some of which have reached late-stage clinical or commercial status in select markets.[2][9][10]
- Therapeutic areas
- PulmonologyPsychiatryDermatologyInfectious Diseases
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)[10]Topical formulations[2]
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
No specific major pharmaceutical partnerships disclosed publicly as of current search results. The company highlights "strategic partnerships worldwide" but does not list names.[1]
Beyond the preview
Go deeper on Ark Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ark Biosciences.